scispace - formally typeset
Search or ask a question
Institution

Clinical Emergency Hospital Bucharest

HealthcareBucharest, Romania
About: Clinical Emergency Hospital Bucharest is a healthcare organization based out in Bucharest, Romania. It is known for research contribution in the topics: Population & Medicine. The organization has 381 authors who have published 276 publications receiving 2188 citations. The organization is also known as: Floreasca Hospital & Spitalul Floreasca.


Papers
More filters
Proceedings ArticleDOI
01 Jun 2017
TL;DR: In this article, a gas chromatograph coupled with a mass spectrometer (GC-MS) Varian was used to identify the cocaine and its metabolite ethylbenzoylecgonine.
Abstract: Mass spectrometry is an optoelectronic method of determining organic substances by comparing their mass spectrum with mass spectra found in system libraries. In the case of biological products, substances of interest, biotic or xenobiotics, may be “hidden” from the background of the analyzed matrix noise, which alters the major aspect of the mass spectrum obtained and faces the impossibility of their identification. A gas chromatograph coupled with mass spectrometer (GC-MS) Varian, was used to develop the application. Authors presented two methods for increase the sensitivity or the signal/noise ratio for identification the cocaine and their metabolite ethylbenzoylecgonine (EBE).

1 citations

Journal ArticleDOI
01 Jun 2020
TL;DR: The aim of the study was to demonstrate this particular distribution of blood vessels through cadaver dissection and to note the resources available to diagnose mesenteric lesions, to highlight the importance of complete knowledge of the anatomy and the particular Distribution of the main arterial and venous trunks.
Abstract: Abstract Mesenteric lesions in abdominal trauma are encountered in 3% of the cases. Diagnosis of these lesions is difficult, which translates into important delays until surgery that affects patient survival. The short-term consequences of mesenteric lesions translate in bowel ischemia or important blood loss. If a lesion is confirmed after imagistic investigations, one must have complete knowledge of the anatomy and the particular distribution of the main arterial and venous trunks to predict the region of the small bowel that will have to be observed or resected if surgery is required. The aim of our study was to demonstrate this particular distribution of blood vessels through cadaver dissection and to note the resources available to diagnose such lesions.
Journal ArticleDOI
TL;DR: In this article , the authors evaluated the prevalence of T. gondii IgG, IgM and IgA antibodies in women of reproductive age residing in Western Romania and assessed the value of adding a T.gondii IGA test to the serologic panel for the diagnosis of toxoplasmosis, including the detection of a recently acquired infection.
Abstract: Toxoplasma gondii, a zoonotic protozoan parasite, has the capacity to infect the fetus if the pregnant woman primarily acquires the infection during pregnancy. We evaluated the prevalence of T. gondii IgG, IgM and IgA antibodies in women of reproductive age residing in Western Romania. We also assessed the value of adding a T. gondii IgA test to the serologic panel for the diagnosis of toxoplasmosis, including the detection of a recently acquired infection. Serologic testing to demonstrate the presence of T. gondii IgG antibodies was conducted in 1317 females aged 15−45 years. T. gondii IgM and IgA antibody tests were performed in those with detectable IgG antibodies and IgG avidity test was performed if IgM and/or IgA screening test results were positive. T. gondii IgG were detected in 607 (46.09%; 95%CI: 43.41−48.79) of 1317 study participants and IgG seroprevalence tended to increase with age from 35.44% (95%CI: 29.89−41.30) in age group 15−24 years to 62.85% (95%CI: 56.57−68.82) in age group 35−45 years, showing a significant age-associated increase (p < 0.001). Of the 607 persons with detectable T. gondii IgG antibodies, T. gondii IgM antibodies were demonstrated in 8.90% (95%CI: 6.88−11.43), T. gondii IgA in 1.65% (95%CI: 0.90−3.01) and both T. gondii IgM and IgA in 0.99% (95%CI: 0.45−2.14). The prevalence of IgA antibodies tended to decrease with increasing avidity, from 75% (95%CI: 19.41−99.37) in samples with low avidity to 11.76% (95%CI: 4.44−23.87) in those with high avidity (p = 0.01). Of the study participants who were positive for both T. gondii IgM and IgA antibodies, 66.67% had low or equivocal IgG avidity test results compared to 6.25% who tested positive for IgM, were negative for IgA and in whom low or equivocal IgG avidity test results were noted (p = 0.001). This study indicates that in Western Romania, T. gondii IgG seroprevalence is high in females of reproductive age and T. gondii IgA antibodies may be rarely detected during a serologic screening. However, in individuals with demonstrable T. gondii IgG and IgM antibodies, testing for T. gondii IgA may improve the rate for the detection of a recently acquired toxoplasmosis.
Journal ArticleDOI
TL;DR: The outcome of the patient and the benefit of bone substitutes for a rapid recovery of trauma patients, with major impact on social and professional recovery are demonstrated.
Abstract: Modern traumatology is characterized by high energy trauma, simultaneously affecting parts of the body especially in young patients. One of the most severe aspects resulting of high energy trauma is that of multiple skeletal injuries, with bone loss, which require complex treatment; this refers both to methods of filling the bone defects and to interdisciplinary approach whenever soft tissues are injured, as well. This case demonstrate the impact of modern approach in high energy trauma, with multiple aspects: bone substitutes as effective technique of bone filling and prevention of septic complications, as well as team work for concomitant treatment of associated injuries. The outcome of the patient, compared to the initial status, demonstrate the benefit of bone substitutes for a rapid recovery of trauma patients, with major impact on social and professional recovery.
Journal Article
TL;DR: Effective alternative for unresectable primary hepatic tumours (big size, hepatic dysfunction, and other surgical risk factors) is endovascular interventional treatment, and chemoembolization was better than procedures without Lipiodol or embolic materials.
Abstract: First transcatheter embolization of hepatic artery has been materializing in 1974, in France, for unresectable hepatic tumours. Then, this treatment has become use enough in many countries, especially in Japan, where primary hepatic tumours are very frequent. In this article, we present procedures of interventional endovascular treatment for primary hepatic tumours: chemoembolization, intra–arterial chemotherapy. The study comprises patients with primary hepatic tumours investigated by hepatic–ultrasound and contrast–enhanced CT or MRI. DSA–hepatic angiography is very important to verify the accessory hepatic supply. It has been performed selective catheterization of right/left hepatic branches followed by cytostatics injection. Most of the patients have benefit by hepatic chemoembolization (cytostatics, Lipiodol and embolic materials). The selective intra–arterial chemotherapy (cytostatics without Lipiodol) was performing in cases with contraindications for Lipiodol or embolic materials injection (cirrhosis–Child C, thrombosis of portal vein, hepatic insufficiency). For treatment of primary hepatic tumours we use 5–F–Uracil, Farmarubicin and Mytomicin C. Less numbers of the reservoirs were placed because financial causes. Chemoembolization was better than procedures without Lipiodol or embolic materials. Lipiodol reached in tumoural tissue and the distribution of Lipiodol harmonises with degree of vascularisation. After the chemoembolization procedure, the diameter of tumours decreased gradually depending on the size of tumour. Effective alternative for unresectable primary hepatic tumours (big size, hepatic dysfunction, and other surgical risk factors) is endovascular interventional treatment.

Authors

Showing all 397 results

Network Information
Related Institutions (5)
Anhui Medical University
15.6K papers, 255.2K citations

71% related

University of Thessaly
13.3K papers, 290.8K citations

70% related

Tehran University of Medical Sciences
57.2K papers, 878.5K citations

70% related

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
15.4K papers, 434.4K citations

70% related

Research Triangle Park
35.8K papers, 1.6M citations

69% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20239
202219
202141
202057
201931
201814